HelpAcademyLoginJoin us as a Member

STANDARD BIOTOOLS INC.

Sign in to save STANDARD BIOTOOLS INC. to a watchlist Sign in to set an alert for STANDARD BIOTOOLS INC.
Tickers
LAB
Headquarters
Not recorded
SEC CIK
0001162194
Website
Not recorded

Closing prices

Latest close, 0.62

Closing prices for LAB249 stored closes for LAB from 3 Nov 2025 to 29 Oct 2026. Lowest 0.60 on 26 Oct 2026, highest 1.68 on 22 Dec 2025, latest 0.62 on 29 Oct 2026.Close0.501.001.502.003 Nov 20251 May 202629 Oct 2026
249 stored closes, oldest first. End of day, not intraday.

Source: Massive Closing prices as of End-of-day prices, not live

Massive Basic, non-business use; display licence needed before launch (D-1). Marketstack is kept as the backup source.

Not investment advice. End-of-day closing prices, not live quotes.

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

No Drugs@FDA application has a sponsor name that matches this company.

Data provided by the U.S. Food and Drug Administration (Drugs@FDA). Sponsors are matched to companies by name; subsidiaries do not link.

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

Latest value of each metric as reported to the SEC
MetricReported valuePeriodFiling
Revenue20,104,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Revenue on sec.gov (opens in a new tab)Filed
Net income (loss)−26,758,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Net income (loss) on sec.gov (opens in a new tab)Filed
Research and development expense1,976,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Research and development expense on sec.gov (opens in a new tab)Filed
Operating expenses35,923,000 USD 1 Apr 2026 to 30 Jun 2026 FY2026 Q210-Q for Operating expenses on sec.gov (opens in a new tab)Filed
Cash and cash equivalents270,026,000 USD At 30 Jun 2026 FY2026 Q210-Q for Cash and cash equivalents on sec.gov (opens in a new tab)Filed
Short-term investments and marketable securities206,693,000 USD At 30 Jun 2026 FY2026 Q210-Q for Short-term investments and marketable securities on sec.gov (opens in a new tab)Filed
Total liabilities87,247,000 USD At 30 Jun 2026 FY2026 Q210-Q for Total liabilities on sec.gov (opens in a new tab)Filed
Stockholders' equity539,971,000 USD At 30 Jun 2026 FY2026 Q210-Q for Stockholders' equity on sec.gov (opens in a new tab)Filed
Common shares outstanding (cover page)392,578,808 shares At 3 Aug 2026 FY2026 Q210-Q for Common shares outstanding (cover page) on sec.gov (opens in a new tab)Filed

History

Revenue, newest period first
PeriodReported valueFiling
1 Apr 2026 to 30 Jun 2026 FY2026 Q220,104,000 USD10-Q filed 5 Aug 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2026 to 31 Mar 2026 FY2026 Q121,146,000 USD10-Q filed 6 May 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2025 to 31 Dec 2025 FY202585,331,000 USD10-K filed 16 Mar 2026 on sec.gov (opens in a new tab)Filed
1 Jul 2025 to 30 Sep 2025 FY2025 Q319,552,000 USD10-Q filed 4 Nov 2025 on sec.gov (opens in a new tab)Filed
1 Apr 2025 to 30 Jun 2025 FY2026 Q221,762,000 USD10-Q filed 5 Aug 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2025 to 31 Mar 2025 FY2026 Q120,222,000 USD10-Q filed 6 May 2026 on sec.gov (opens in a new tab)Filed
1 Jan 2024 to 31 Dec 2024 FY202591,008,000 USD10-K filed 16 Mar 2026 on sec.gov (opens in a new tab)Filed
1 Jul 2024 to 30 Sep 2024 FY2025 Q322,086,000 USD10-Q filed 4 Nov 2025 on sec.gov (opens in a new tab)Filed

The newest 12 periods of each metric are listed; older ones are on sec.gov.

Values as reported in the company's XBRL filings to the SEC, one per calendar period (SEC frames); not adjusted, not audited by HealthTrade, and not investment advice.

Source: SEC XBRL company facts (opens in a new tab) · Licence: public-domain · as of 2026-10-25 · read

SEC filings

SEC filings from STANDARD BIOTOOLS INC., newest first
FormFiledWhat it coversDocument
424B3 Form 424B3 View Form 424B3 filed 30 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001140361-26-041305 (opens in a new tab)
424B3 Form 424B3 View Form 424B3 filed 21 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001140361-26-040401 (opens in a new tab)
8-K Current report (8-K)
  • Regulation FD disclosure (Item 7.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 5 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001140361-26-038624 (opens in a new tab)
8-K Current report (8-K)
  • Entry into a material definitive agreement (Item 1.01)
  • Termination of a material definitive agreement (Item 1.02)
  • Regulation FD disclosure (Item 7.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 30 Sep 2026 on sec.gov (opens in a new tab)Filing index for 0001140361-26-038110 (opens in a new tab)
4Event 20 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 24 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-363767 (opens in a new tab)
4Event 20 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 24 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-363762 (opens in a new tab)
4Event 20 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 24 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-363758 (opens in a new tab)
10-QEvent 30 Jun 2026 Quarterly report (10-Q) View Quarterly report (10-Q) filed 5 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-335103 (opens in a new tab)
8-K Current report (8-K)
  • Results of operations and financial condition (Item 2.02)
  • Regulation FD disclosure (Item 7.01)
  • Financial statements and exhibits (Item 9.01)
View Current report (8-K) filed 5 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-335106 (opens in a new tab)
4Event 3 Aug 2026 Insider transaction report (Form 4) View Insider transaction report (Form 4) filed 4 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001193125-26-333225 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Insider transactions

All rows for STANDARD BIOTOOLS INC. on Insider Trades

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P
None in this period
Sells code S
None in this period
Other all other codes
4 transactions: grants, exercises, tax withholding, gifts and similar

Last transaction:

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Nothing on this page is investment advice.